ALGERT GLOBAL LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1275218 SAN FRANCISCO, CA

Position in CRNX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,714,147

-$838,021 QoQ

Shares Held

72,532

-25.8% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#89

of 266 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. CRNX ranks #63 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PCVX	Vaxcyte, Inc.	515,343	$29,956,888
2	ROIV	Roivant Sciences Ltd.	845,118	$29,908,726
3	XENE	Xenon Pharmaceuticals Inc.	419,773	$25,337,498
4	CLDX	Celldex Therapeutics, Inc.	647,836	$24,105,977
5	AXSM	Axsome Therapeutics, Inc.	95,335	$23,335,147
6	SNDX	Syndax Pharmaceuticals Inc	1,051,465	$22,985,024
7	MRNA	Moderna, Inc.	274,820	$19,245,644
8	MLYS	Mineralys Therapeutics, Inc.	649,027	$17,510,748

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,714,147	72,532	-25.8%	Shares	Sole	2026-08-13
2026-03-31	$3,552,168	97,802	+272.1%	Shares	Sole	2026-05-14
2025-03-31	$881,665	26,287	-8.7%	Shares	Sole	2025-05-13
2024-12-31	$1,471,368	28,777	-32.7%	Shares	Sole	2025-02-14
2024-09-30	$2,185,904	42,777	+2.6%	Shares	Sole	2024-11-12
2024-06-30	$1,868,056	41,707	+19.0%	Shares	Sole	2024-08-15
2024-03-31	$1,640,222	35,040	+98.2%	Shares	Sole	2024-05-15
2023-12-31	$629,054	17,680	-5.5%	Shares	Sole	2024-02-14
2023-03-31	$300,482	18,710	+7.5%	Shares	Sole	2023-05-12
2022-12-31	$318,529	17,406	0.0%	Shares	Sole	2023-02-14
2022-09-30	$341,853	17,406	-13.3%	Shares	Sole	2022-11-15
2022-06-30	$374,473	20,079	-19.6%	Shares	Sole	2022-08-15
2022-03-31	$547,850	24,959	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.